1. A novel vitamin D3analogue, 22-oxa-1, 25-dihydroxyvitamin D3 inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia;ABE;Endocrinology,1991
2. Antitumor effect of 22-oxa-calcitriol, a non calcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen;ABE-HASHIMOTO;Cancer Research,1993
3. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential;BIKLE;Endocrinology,1992
4. 1,25-Dihydroxyvitamin D3and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accummulation of cells in G1;BLUTT;Endocrinology,1997
5. Effects of retinoic acid on cell differentiation and reverse toward normal in human endometrial (RL95-2) cells;CARTER;Anticancer Research,1996